BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/24/2025 5:39:17 AM | Browse: 185 | Download: 672
 |
Received |
|
2024-07-19 17:42 |
|
Peer-Review Started |
|
2024-07-19 17:42 |
|
First Decision by Editorial Office Director |
|
2024-11-11 08:34 |
|
Return for Revision |
|
2024-11-11 08:34 |
|
Revised |
|
2024-11-21 10:56 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2024-12-17 02:46 |
|
Second Decision by Editor-in-Chief |
|
2024-12-20 00:38 |
|
Final Decision by Editorial Office Director |
|
2025-01-14 06:48 |
|
Articles in Press |
|
2025-01-14 06:48 |
|
Edit the Manuscript by Language Editor |
|
2025-01-19 10:15 |
|
Typeset the Manuscript |
|
2025-02-05 09:26 |
|
Publish the Manuscript Online |
|
2025-02-24 05:39 |
| ISSN |
1948-0210 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Medicine, Research & Experimental |
| Manuscript Type |
Minireviews |
| Article Title |
Induced pluripotent stem cells-derived mesenchymal stem cells for modelling and treating non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: Challenges and opportunities
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Bárbara Silva and José Bragança |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| American Heart Association Award |
24IVPHA1288417 |
| FCT Fellowships |
2022.13253.BDANA |
|
| Corresponding Author |
José Bragança, Associate Professor, PhD, Faculty of Medicine and Biomedical Sciences, Algarve Biomedical Center-Research Institute, University of Algarve, Campus of Gambelas, Building 8, Room 2.22, Faro 8005-139, Portugal. jebraganca@ualg.pt |
| Key Words |
Non-alcoholic fatty liver disease; Non-alcoholic steatohepatitis; Mesenchymal stem cells; Induced pluripotent stem cells; In vitro liver models |
| Core Tip |
Induced pluripotent stem cells (iPSCs) show promise for modelling and treating non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. iPSCs can generate various cell types, including cells for therapy or disease modelling. Challenges remain, but iPSCs offer potential for drug discovery and personalized medicine approaches for non-alcoholic fatty liver disease/non-alcoholic steatohepatitis. |
| Publish Date |
2025-02-24 05:39 |
| Citation |
Silva B, Bragança J. Induced pluripotent stem cells-derived mesenchymal stem cells for modelling and treating non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: Challenges and opportunities. World J Stem Cells 2025; 17(2): 99331 |
| URL |
https://www.wjgnet.com/1948-0210/full/v17/i2/99331.htm |
| DOI |
https://dx.doi.org/10.4252/wjsc.v17.i2.99331 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
